Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Gynecol Oncol. 2015 Aug 7;139(1):23–29. doi: 10.1016/j.ygyno.2015.08.001

Table 1.

Analysis of assosiation between the 51 patients’ age and tumor stage with overall survival (OS)

Duke p-value
Short Survival (OS ≤ 3 years) Long Survival (OS ≥ 7 years)
Stage III 23 23 0.004
IV 5 0
Age 59 (37–79) 62 (33–78) 0.68

The stage of the tumor (III vs. IV) was significantly associated with patients OS (p-value= 0.004). However, there were only 5 patients in the stage IV group and none of the patients were in the long survival category. Age of the patients at the time of diagnosis was not significantly associated with OS (p-values= 0.68).